Bariatrics clinical trial - Rhythm Pharmaceuticals, Inc.

Bariatrics

Status:

Enrolling by invitation

ClinicalTrials.gov:

NCT05194124

Rhythm Pharmaceuticals, Inc. -RM-493-037

Drug

Setmelanotide/Placebo

Phase

III

Condition

Obesity